Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy

The aim of the present study was to evaluate 29 whole blood or serum indicators to identify factors able to predict clinical outcome following cytokine-induced killer (CIK) cell therapy combined with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC), and to evaluate the 5-yea...

Descripción completa

Detalles Bibliográficos
Autores principales: JIA, HEJIN, TIAN, YAPING, JIANG, CHAO GUANG, HAN, WEIDONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840551/
https://www.ncbi.nlm.nih.gov/pubmed/27168779
http://dx.doi.org/10.3892/etm.2016.3102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840551/
https://www.ncbi.nlm.nih.gov/pubmed/27168779
http://dx.doi.org/10.3892/etm.2016.3102

Ejemplares similares